Clinical Trial Detail

NCT ID NCT02592577
Title MAGE A10c796T for Advanced NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Adaptimmune
Indications

lung non-small cell carcinoma

Therapies
Age Groups: adult senior

No variant requirements are available.